Kerri Nottage, MD

    Kerri Nottage, MD

    Assistant Member, St. Jude Faculty

    Departments

    Hematology

    Contact Information

    Kerri Nottage, MD
    Hematology
    MS 800, Room R5013
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: kerri.nottage@stjude.org
    Phone: (901) 595-6216
    FAX: (901) 595-2813

    Education

    BS – University of Rhode Island, Kingston, Rhode Island
    MD – Brown University Medical School, Providence, Rhode Island
    Internship/Residency (Internal Medicine and Pediatrics) – Rhode Island Hospital/Hasbro Children’s Hospital
    Fellowship (Pediatric Hematology/Oncology) - St. Jude Children’s Research Hospital


    Research Interests


    Selected Publications

    Nottage KA, Hankins JS, Smeltzer M, Mzayek F, Wang WC, Aygun B, Gurney JG. Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program. PLoS One 8(8):e72077, 2013.

    Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk Lymphoma 54(8):1719-23, 2013. PMID: 23163568

    Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, Green DM, Armstrong GT, Nottage KA, Jones KE, Sklar CA, Srivastava DK, Robison LL. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 309(22):2371-81, 2013.

    Gawade PL, Ness KK, Sharma S, Li Z, Srivastava DK, Spunt SL, Nottage K, Krasin MJ, Hudson MM, Kaste SC. Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia. J Cancer Surviv Dec;6(4):388-97, 2012. PMID: 22956305

    Nottage K, McFarlane J, Krasin MJ, Li C, Srivastava D, Robison LL, Hudson MM. Secondary colorectal carcinoma after childhood cancer. J Clin Oncol 30(20):2552-8, 2012. PMID: 22665546

    Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, Leisenring W, Meadows AT, Srivastava DK, Robison LL, Armstrong GT. Long-Term Risk for Secondary Leukemia after Treatment for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Blood 117(23):6315-8, 2011. PMID: 21498675

    Jeng MR, Naidu PE, Rieman MD, Rodriguez-Galindo C, Nottage KA, Thornton DT, Li CS, Wang WC. Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia. Pediatr Blood Cancer 45(2):170-5, 2005. PMID: 15593082

    Last update: September 2013